PT Murni Sadar (MTMH) Fundamentals 2026 — P/E 47.9x, Revenue Analysis | SniperIQ
PT Murni Sadar (MTMH) is a ID-listed Healthcare company in Medical - Care Facilities with a market capitalization of Rp1.94T, trading at Rp940.00 on the JKT. This SniperIQ fundamentals page covers PT Murni Sadar's valuation (P/E 47.9x, P/B 1.3x), profitability (net margin 2.8%), revenue (Rp1.36T in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is PT Murni Sadar's market cap?
PT Murni Sadar (MTMH) has a market capitalization of approximately Rp1.94T, trading at Rp940.00 on the JKT. Market cap moves with the live share price.
What is PT Murni Sadar's P/E ratio?
PT Murni Sadar's trailing twelve-month P/E ratio is 47.9x, with a price-to-book (P/B) of 1.3x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is PT Murni Sadar?
PT Murni Sadar runs a net profit margin of 2.8%, a gross margin of 25.1%, and an operating margin of 8.5%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does PT Murni Sadar generate?
PT Murni Sadar reported revenue of Rp1.36T for fiscal year 2025, with net income of Rp43.6B and earnings per share (EPS) of 21.09. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does PT Murni Sadar pay a dividend?
PT Murni Sadar offers a trailing dividend yield of about 0.3%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is PT Murni Sadar financially healthy?
PT Murni Sadar carries a debt-to-equity ratio of 0.56x and a current ratio of 0.42x, with a market beta of 0.16. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is PT Murni Sadar a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For PT Murni Sadar (MTMH) the key facts are: market cap Rp1.94T, P/E 47.9x, revenue Rp1.36T, 52-week range 845-1635. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track PT Murni Sadar's full fundamentals live
Get PT Murni Sadar's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.